Yahoo

3 U.S. Value Stocks Drawing Attention as Investors Rethink AI Spending

Explore stocks on Coinbase

Big tech just hit a speed bump as Alphabet's AI spending and revenue miss pulled attention away from crowded mega caps and toward overlooked corners of the market. That shift has put smaller cyclical and financial value stocks back on radar for investors worried about AI cash burn and uncertain interest rates. This article walks through three U.S. small and mid caps that sit squarely in the path of this rotation.

The three examples below are just a small sample, and the full screen surfaced 7 more U.S. small and mid caps with similarly detailed stories that are not covered here. If you want to identify and analyze your own highest conviction plays across this group, head straight into the U.S. Small- and Mid-Cap Cyclical & Financial Value Stocks screener .

Avient (AVNT)

Overview:Avient formulates specialty polymer materials, colors, additives and inks used across packaging, healthcare, consumer goods, transportation, construction and industrial products, giving investors cyclical exposure to real economy demand.

Operations:Avient generates about US$2.1b from Color Additives and Inks and US$1.3b from Specialty Engineered Materials, with a small corporate loss.

Market Cap:US$3.9b

Avient fits this cyclical materials screen because its plastics, additives and inks are tied directly to packaging, consumer and industrial volumes. This gives the stock potential leverage if investors keep shifting away from cash hungry mega cap AI stories toward cash generative, economically sensitive manufacturers.

"Although balance sheet metrics are improving with US$200 million of debt repaid over 12 months and a further US$100 million to US$150 million planned, the focus on deleveraging ties up cash that could otherwise support growth investments. Any shortfall in underlying free cash flow would therefore pressure both future shareholder returns and interest expense progress."

What happens if one unseen pressure on Avient's margin mix collides with that capital restraint will matter far more than headline earnings.

If that margin squeeze risk is what you keep circling back to, read the full narrative for Avient to see how Avient could turn constraint into acceleration.

NYSE:AVNT Revenue & Expenses Breakdown as at Oct 2026
NYSE:AVNT Revenue & Expenses Breakdown as at Oct 2026

Minerals Technologies (MTX)

Overview:Minerals Technologies produces specialty mineral products for consumer goods, industrial casting, environmental infrastructure and water treatment, giving investors direct exposure to real economy demand.

Operations:Minerals Technologies generates about US$1.1b from Consumer & Specialties and US$1.0b from Engineered Solutions, supported by primarily U.S. revenue.

Market Cap:US$1.9b

Minerals Technologies fits this cyclical and financial value screen because it is tied to industrial output, consumer staples and infrastructure projects, not AI hype. Shifting attention toward cash generative materials businesses puts its real world footprint back in focus.

"PFAS remediation solutions like FLUORO-SORB, already installed in about 10 municipal drinking water plants and specified in roughly 10 more, together with growing pilot activity in multiple regions, can expand Minerals Technologies' addressable market and support higher environmental product revenue and operating income."

What happens if one unresolved legal and cost overhang collides with that higher value mix will matter far more than headline earnings.

That collision risk is exactly why reading the full narrative for Minerals Technologies can clarify how Minerals Technologies might turn PFAS obligations into a more compelling water treatment story.

NYSE:MTX Revenue & Expenses Breakdown as at Oct 2026
NYSE:MTX Revenue & Expenses Breakdown as at Oct 2026

AdvanSix (ASIX)

Overview:AdvanSix is an integrated U.S. chemicals producer that makes Nylon 6 resins, fertilizers and solvents tied to industrial and consumer cycles.

Operations:AdvanSix generates about US$1.6b from Chemical Manufacturing, with roughly US$1.3b from the United States and about US$239 million from international customers.

Market Cap:US$419 million

AdvanSix fits this small and mid cap cyclical materials screen because its nylon, fertilizer and solvent products track real world industrial and consumer demand rather than AI spending headlines.

"The market is pricing ASIX for a permanent impairment of its earnings power. We view this as a temporary cyclical trough in the nylon and chemical intermediates markets, obscured by the noise of raw material pass-throughs."

The way this integrated chemistry platform converts that cycle into steadier margins could shape the value story.

To see how that earnings reset could re-rate AdvanSix, go straight to the full narrative for AdvanSix for the full cycle and margin story.

NYSE:ASIX Earnings & Revenue History as at Oct 2026
NYSE:ASIX Earnings & Revenue History as at Oct 2026

Seeking Fresh Alternatives Beyond Big Tech?

The next breakout groups are rarely crowded at the start. Momentum can shift quickly, and under the radar for now ideas may gain attention fast, so consider exploring them early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: